Journey Medical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DERM and other ETFs, options, and stocks.About DERM
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend.
CEOClaude Maraoui
CEOClaude Maraoui
Employees41
Employees41
HeadquartersScottsdale, Arizona
HeadquartersScottsdale, Arizona
Founded2014
Founded2014
Employees41
Employees41
DERM Key Statistics
Market cap232.05M
Market cap232.05M
Price-Earnings ratio-22.62
Price-Earnings ratio-22.62
Dividend yield—
Dividend yield—
Average volume233.95K
Average volume233.95K
High today$9.30
High today$9.30
Low today$8.76
Low today$8.76
Open price$8.91
Open price$8.91
Volume186.13K
Volume186.13K
52 Week high$9.30
52 Week high$9.30
52 Week low$3.54
52 Week low$3.54
Stock Snapshot
Journey Medical(DERM) stock is priced at $8.84, giving the company a market capitalization of 232.05M. It carries a P/E multiple of -22.62.
On 2025-11-06, Journey Medical(DERM) stock moved within a range of $8.76 to $9.30. With shares now at $8.84, the stock is trading +1.0% above its intraday low and -4.9% below the session's peak.
Trading volume for Journey Medical(DERM) stock has reached 186.13K, versus its average volume of 233.95K.
Over the past 52 weeks, Journey Medical(DERM) stock has traded between a high of $9.30 and a low of $3.54.
Over the past 52 weeks, Journey Medical(DERM) stock has traded between a high of $9.30 and a low of $3.54.
People also own
Based on the portfolios of people who own DERM. This list is generated using Robinhood data, and it’s not a recommendation.